[Combination therapy of acute leukemia in rats L 5222 with cytoxan and methyl- or cytoxan and n-butyl-n-nitroso urea (author's transl)].
D000208:Acute Disease; D000284:Administration, Oral; D000818:Animals; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D007275:Injections, Intravenous; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008770:Methylnitrosourea / Q000008:administration & dosage / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D051381:Rats; D013997:Time Factors
D009607:Nitrosourea Compounds; D008770:Methylnitrosourea; D003520:Cyclophosphamide
Kombinationstherapie der akuten Rattenleukämie L 5222 mit Endoxan und Methyl- hzw. Endoxan und n-Butyl-Nitrosoharnstoff